This event will be hosted by the Heart Foundation in partnership with the World Heart Federation and the High Blood Pressure Research Council of Australia,
and chaired by Prof. Garry Jennings, Chief Medical Advisor and Interim CEO of the Heart Foundation.

Our global expert panel will discuss:
• Controversies in BP targets and implications for practice post SPRINT trial
• Latest advice for the diagnosis and management of resistant hypertension
• Latest advice on out-of-office blood pressure monitoring
• Digital health tools on the horizon for CVD prevention and monitoring
• Applying new evidence to clinical practice to promote structured CVD prevention strategies

Speakers:

• Prof. Rhian Touyz (International speaker)
  Executive Director and Chief Scientific Officer at the Research Institute of McGill University Health Centre, Montreal, Canada
• Prof. Markus Schlaich
  Dobney Chair in Clinical Research at The University of Western Australia and President of High Blood Pressure Research Council of Australia
• Prof. James Sharman
  Deputy Director and Head of the Blood Pressure Research Group at the Menzies Institute for Medical Research, University of Tasmania
• Prof. Nick Zwar
  GP and Executive Dean of the Faculty of Health Sciences and Medicine at Bond University
• Prof. Garry Jennings (Chair)
  Chief Medical Advisor and Interim CEO of the Heart Foundation

This activity is accredited by the RACGP CPD program for 2 CPD points (Activity no. 295128).

Education provider: Scius Healthcare Solutions.